We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$713B
AUM Growth
+$53.3B
Cap. Flow
+$8.84B
Cap. Flow %
1.24%
Top 10 Hldgs %
20.41%
Holding
5,090
New
62
Increased
3,440
Reduced
905
Closed
188

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$784M
2
AAPL icon
Apple
AAPL
+$427M
3
DHR icon
Danaher
DHR
+$417M
4
PLD icon
Prologis
PLD
+$405M
5
AMZN icon
Amazon
AMZN
+$383M

Sector Composition

Rank Sector Weight
1 Technology 22.94%
2 Healthcare 15.43%
3 Financials 13.92%
4 Consumer Discretionary 9.78%
5 Industrials 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUBN icon
3851
Auburn National Bancorp
AUBN
$91.9M
$328K ﹤0.01%
14,155
-22
-0.2% -$509
LNAI
3852
Lunai Bioworks
LNAI
$10.9M
$328K ﹤0.01%
3,985
+2
+0.1% +$268
AUGX
3853
DELISTED
Augmedix, Inc. Common Stock
AUGX
$328K ﹤0.01%
210,521
-419
-0.2% -$534
VIRX
3854
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$327K ﹤0.01%
224,438
+6,502
+3% +$19K
VORB
3855
DELISTED
Virgin Orbit Holdings, Inc. Common Stock
VORB
$325K ﹤0.01%
176,023
BIOX icon
3856
Bioceres Crop Solutions
BIOX
$22M
$323K ﹤0.01%
26,868
RGF
3857
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
$321K ﹤0.01%
4,046
+36
+0.9% +$2.94K
ALZN icon
3858
Alzamend Neuro
ALZN
$6.56M
$318K ﹤0.01%
418
+29
+7% +$42K
LPCN icon
3859
Lipocine
LPCN
$17.6M
$318K ﹤0.01%
48,827
-119
-0.2% -$867
IMDX
3860
Insight Molecular Diagnostics
IMDX
$156M
$318K ﹤0.01%
49,623
-125
-0.3% -$1.38K
MSPR
3861
DELISTED
MSP Recovery Inc
MSPR
$318K ﹤0.01%
46
+22
+92% +$114K
SILV
3862
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$318K ﹤0.01%
53,180
-780
-1% -$4.65K
HOOK
3863
DELISTED
HOOKIPA Pharma
HOOK
$317K ﹤0.01%
39,188
-95
-0.2% -$1.03K
QCLS
3864
Q/C Technologies Inc
QCLS
$22.9M
$317K ﹤0.01%
92
+1
+1% +$6.29K
ELA icon
3865
Envela
ELA
$446M
$316K ﹤0.01%
60,176
-176
-0.3% -$902
LILM
3866
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$316K ﹤0.01%
277,552
+123,167
+80% +$195K
SURF
3867
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$316K ﹤0.01%
386,312
+13,698
+4% +$13.5K
CAN
3868
Canaan Creative
CAN
$159M
$315K ﹤0.01%
153,381
+1,577
+1% +$4.37K
MIMO
3869
DELISTED
Airspan Networks Holdings Inc
MIMO
$315K ﹤0.01%
241,033
-643
-0.3% -$1.25K
TCRR
3870
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$314K ﹤0.01%
315,377
-773
-0.2% -$1.04K
SRAX
3871
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$314K ﹤0.01%
205,644
+6,639
+3% +$10.7K
QBTS icon
3872
D-Wave Quantum Inc. Common Stock
QBTS
$7.73B
$313K ﹤0.01%
+217,780
New +$769K
VIRC icon
3873
Virco
VIRC
$96.3M
$313K ﹤0.01%
69,465
+1,224
+2% +$5.16K
FTHM icon
3874
Fathom Holdings
FTHM
$25.2M
$312K ﹤0.01%
73,612
+3,959
+6% +$18.7K
LDTC
3875
DELISTED
LeddarTech
LDTC
$312K ﹤0.01%
62,816

Similar funds

Geode Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Geode Capital Management held 5,090 positions worth $713B, up 8.1% from $659B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 4.9%. Geode Capital Management opened 62 new positions and exited 188, leaving the 5,090-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q4 2022 buy was Ferguson: 1,854,192 shares worth $235M.
  • Geode Capital Management added most to Microsoft in Q4 2022, an estimated $784M increase.
  • Geode Capital Management's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $491M.
  • Geode Capital Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $587M.
  • Geode Capital Management's ten largest holdings make up 20% of its $713B portfolio in Q4 2022.
  • Geode Capital Management opened 62 new positions and closed 188 in Q4 2022.
  • Geode Capital Management's portfolio value rose 8.1% quarter-over-quarter to $713B.

Based on Geode Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.